APR 05, 2020 2:53 PM PDT

Headlice Drug Kills COVID-19 Within 48 Hours

WRITTEN BY: Annie Lennon

As death tolls continue to rise from COVID-19, the scramble for new treatments to counter the virus surges on. Now, researchers have identified an anti-parasitic drug that is able to kill off the virus in cell cultures within just 48 hours. Widely available around the world, the researchers hope that it may soon be used to fight off the virus.

Initially discovered by Dr Kylie Wagstaff from the Monash Biomedicine Discovery Institute in Australia in 2012, it was soon recognized for its antiviral effects. Aside from potentially being able to fend off the novel coronavirus, the drug, known as Ivermectin, has also shown to be effective against other viruses including HIV, Dengue, influenza and Zika virus in vitro. Thus, as soon as the pandemic was confirmed to have begun, Wagstaff and her team are said to have begun research looking at Ivermectin’s potential for fighting off SARS-CoV-2. 

Wagstaff said, “We need to figure out now whether the dosage you can use it at in humans will be effective -- that's the next step...In times when we're having a global pandemic and there isn't an approved treatment, if we had a compound that was already available around the world then that might help people sooner. Realistically it's going to be a while before a vaccine is broadly available.”

Although exactly how the drug works against the virus is still unknown, the researchers suspect that it works by stopping the virus from weakening the host cells’ ability to clear it. This comes as a similar mechanism was shown to have been at play when used against other viruses. 

Despite promising results from their early experiments however, the researchers say the drug still needs to undergo further preclinical testing before it may even reach clinical trials and then treatment status. Further funding is also urgently required or this process to continue. 

The study’s first author, Dr Leon Caly, nevertheless said, “As the virologist who was part of the team who were first to isolate and share SARS-COV2 outside of China in January 2020, I am excited about the prospect of Ivermectin being used as a potential drug against COVID-19.”


Sources: Science Daily, SciTech Daily

About the Author
  • Science writer with keen interests in technology and behavioral biology. Her current focus is on the interplay between these fields to create meaningful interactions, applications and environments.
You May Also Like
APR 09, 2020
Drug Discovery & Development
APR 09, 2020
4 Natural Antihistamines with No Side Effects
Over-the-counter antihistamine treatments are known to be effective for relieving allergic symptoms. However, they are a ...
APR 15, 2020
Chemistry & Physics
APR 15, 2020
Could this drug help people with SAD?
Have you ever been sad in the winter? If so, you’re not alone. Medaka fish feel it too. Seasonal affective disorde ...
APR 17, 2020
Drug Discovery & Development
APR 17, 2020
Gilead's Remdesivir Trial Sees Rapid Recoveries from COVID-19
Early results from a Chicago hospital treating patients with Gilead Sciences’ antiviral drug remdesivir for severe ...
APR 20, 2020
Cancer
APR 20, 2020
Expanding the Diagnostic Toolkit in Cancer Research with isomiRNAs
Esophageal cancers are one of the more common cancers around the world, with an unfortunately poor prognosis. The five-y ...
MAY 02, 2020
Cancer
MAY 02, 2020
Tracking DNA Methylation as a Prognostic Marker
In the modern age of biological research, one of the tools that have become readily available in the ever-increasing dat ...
MAY 12, 2020
Cannabis Sciences
MAY 12, 2020
Study Shows Cannabis May Block COVID-19 Infection
Researchers from the University of Lethbridge, Canada, have found that cannabis may be able to block COVID-19 infections ...
Loading Comments...